2 hours Leerink Partnrs Issues Negative Outlook for Biogen EarningsMarketBeat
Biogen Inc. (NASDAQ:BIIB – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2024 EPS estimates for Biogen in a report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now forecasts that the biotechnology company will po…
Biogen (BIIB) · Earnings · Nasdaq 100
X